Evidence map›Paper›PMID 28424471›Full record

ArticleScientific reports2017

Human Luteinizing Hormone and Chorionic Gonadotropin Display Biased Agonism at the LH and LH/CG Receptors.

Laura Riccetti, Romain Yvinec, Danièle Klett, Nathalie Gallay, Yves Combarnous, Eric Reiter, Manuela Simoni, Livio Casarini, Mohammed Akli Ayoub

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04189133 (Pharmacodynamics and Safety of Human Recombinant Luteinising Hormone in Hypogonadotropic Hypogonadal Men), which is not on this map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
12.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04189133 phase2unknown statusnot on this mapstarted 2022, after this paper: background citation

Pharmacodynamics and Safety of Human Recombinant Luteinising Hormone in Hypogonadotropic Hypogonadal Men

TypeinterventionalSponsorAzienda Ospedaliero-Universitaria di ModenaRan2022 to 2026Enrolled32ConditionsAcquired Hypogonadotropic HypogonadismArmsLutropin alfa, Human chorionic gonadotropin
3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 104 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Review
  5. Biased signalingActa pharmaceutica Sinica. B · 2025
    Review
  6. Pharmacogenomic of LH and its receptor: are we ready for clinical practice?Reproductive biology and endocrinology : RB&E · 2025
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Laura RiccettiUnit of Endocrinology, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.
Romain YvinecPRC, INRA, CNRS, Université François Rabelais-Tours, 37380, Nouzilly, France.
Danièle KlettPRC, INRA, CNRS, Université François Rabelais-Tours, 37380, Nouzilly, France.
Nathalie GallayPRC, INRA, CNRS, Université François Rabelais-Tours, 37380, Nouzilly, France.
Yves CombarnousPRC, INRA, CNRS, Université François Rabelais-Tours, 37380, Nouzilly, France.
Eric ReiterPRC, INRA, CNRS, Université François Rabelais-Tours, 37380, Nouzilly, France. Eric.Reiter@inra.fr.
Manuela SimoniUnit of Endocrinology, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.
Livio CasariniUnit of Endocrinology, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy. livio.casarini@unimore.it.
Mohammed Akli AyoubPRC, INRA, CNRS, Université François Rabelais-Tours, 37380, Nouzilly, France. mayoub@uaeu.ac.ae.
Physiologie de la Reproduction et des Comportements · FRCentre National de la Recherche Scientifique · FRPoliclinico di Modena · ITUniversité de Tours · FRUniversity of Modena and Reggio Emilia · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human luteinizing hormone (LH) and chorionic gonadotropin (hCG) have been considered biologically equivalent because of their structural similarities and their binding to the same receptor; the LH/CGR. However, accumulating evidence suggest that LH/CGR differentially responds to the two hormones triggering differential intracellular signaling and steroidogenesis. The mechanistic basis of such differential responses remains mostly unknown. Here, we compared the abilities of recombinant rhLH and rhCG to elicit cAMP, β-arrestin 2 activation, and steroidogenesis in HEK293 cells and mouse Leydig tumor cells (mLTC-1). For this, BRET and FRET technologies were used allowing quantitative analyses of hormone activities in real-time and in living cells. Our data indicate that rhLH and rhCG differentially promote cell responses mediated by LH/CGR revealing interesting divergences in their potencies, efficacies and kinetics: rhCG was more potent than rhLH in both HEK293 and mLTC-1 cells. Interestingly, partial effects of rhLH were found on β-arrestin recruitment and on progesterone production compared to rhCG. Such a link was further supported by knockdown experiments. These pharmacological differences demonstrate that rhLH and rhCG act as natural biased agonists. The discovery of novel mechanisms associated with gonadotropin-specific action may ultimately help improve and personalize assisted reproduction technologies.

Indexed as

Animalsbeta-Arrestin 1Chorionic GonadotropinCyclic AMPHEK293 CellsHumansLuteinizing HormoneMiceProgesteroneReceptors, LHRecombinant Proteinsbeta-Arrestin 1Chorionic GonadotropinCyclic AMPLuteinizing HormoneProgesteroneReceptors, LHRecombinant Proteins

Identifiers

PMID28424471
PMCPMC5430435
OpenAlexW2606498093

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.